Patents by Inventor Jeffrey Howe

Jeffrey Howe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050050161
    Abstract: A subscriber login server is used for managing a subscriber login session. The login server is associated with a DHCP server for configuring a premise equipment device and operator-managed device. A subscriber login client at the premise equipment device securely communicates login username and password identifiers to the subscriber login server without using PPP technology. The login server retrieves matching identifiers from a RADIUS server and authorizes service with messages to the DHCP server and the CMTS. The login client can emulate a PPP login client so that a user's interface is similar to a PPPoE client. However, a layer-3 CMTS can be used instead of a layer-2 CMTS. In addition, subscriber authentication and accounting using RADIUS are preserved, positive network access control at the CMTS is maintained, and native IP traffic is routed or switched for maximum performance and QoS treatment.
    Type: Application
    Filed: August 30, 2004
    Publication date: March 3, 2005
    Inventors: Erich Arnold, Thomas Cloonan, Jeffrey Howe
  • Publication number: 20040005691
    Abstract: The present invention relates to recombinant human BACE polypeptides. More particularly, the invention relates to recombinant human BACE polypeptides that have a modified amino acid sequence at position 33 of the BACE sequence, as well as to polynucleotides, expression vectors, host cells, and methods for producing the modified recombinant human BACE polypeptides.
    Type: Application
    Filed: February 21, 2003
    Publication date: January 8, 2004
    Inventors: Kuo-Chen Chou, W. Jeffrey Howe
  • Patent number: 6060600
    Abstract: This application discloses novel tetronic acids for the treatment of AIDS and other diseases caused by retroviruses.
    Type: Grant
    Filed: September 17, 1997
    Date of Patent: May 9, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert A. Chruscial, Linda L. Maggiora, Suvit Thaisrivongs, James M. Tustin, Clark W. Smith, Ruben A. Tommasi, Paul A. Aristoff, Harvey I. Skulnick, W. Jeffrey Howe
  • Patent number: 5977169
    Abstract: This invention comprises novel substituted tetronic acid type compounds, 2, 4(3H, 5H)-furandiones, that are useful for the inhibition of the HIV protease enzyme. The compounds may be useful for the treatment of a person with AIDS or AIDS related diseases. The compounds may be used in the attempt to retard the further replication of any retrovirus containing the aspartyl protease enzyme. Compounds are represented by the formula below.
    Type: Grant
    Filed: July 28, 1997
    Date of Patent: November 2, 1999
    Inventors: Robert A. Chrusciel, Linda L. Maggiora, Suvit Thaisrivongs, James M. Tustin, Clark W. Smith, Ruben A. Tommasi, Paul A. Aristoff, Harvey I. Skulnick, W. Jeffrey Howe, Gordon L. Bundy